As of 2026-09-10, the Relative Valuation of Novacyt SA (ALNOV.PA) is (14.33) EUR. This relative valuation is based on P/E multiples. With the latest stock price at 0.50 EUR, the upside of Novacyt SA based on Relative Valuation is -2955.3%.
The range of the Relative Valuation is (13.66) - (13.71) EUR.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 32.6x - 49.2x | 37.8x |
| Forward P/E multiples | 28.4x - 32.7x | 30.7x |
| Fair Price | (13.66) - (13.71) | (14.33) |
| Upside | -2821.4% - -2831.4% | -2955.3% |
| Date | P/E |
| 2026-09-04 | -1.22 |
| 2026-09-03 | -1.21 |
| 2026-09-02 | -1.22 |
| 2026-09-01 | -1.27 |
| 2026-08-31 | -1.20 |
| 2026-08-28 | -1.17 |
| 2026-08-27 | -1.18 |
| 2026-08-26 | -1.21 |
| 2026-08-25 | -1.22 |
| 2026-08-24 | -1.23 |
| 2026-08-21 | -1.27 |
| 2026-08-20 | -1.17 |
| 2026-08-19 | -1.22 |
| 2026-08-18 | -1.30 |
| 2026-08-17 | -1.30 |
| 2026-08-14 | -1.24 |
| 2026-08-13 | -1.23 |
| 2026-08-12 | -1.32 |
| 2026-08-11 | -1.14 |
| 2026-08-10 | -1.10 |
| 2026-08-07 | -1.05 |
| 2026-08-06 | -1.04 |
| 2026-08-05 | -1.04 |
| 2026-08-04 | -1.02 |
| 2026-08-03 | -1.00 |
| 2026-07-31 | -1.02 |
| 2026-07-30 | -1.02 |
| 2026-07-29 | -1.05 |
| 2026-07-28 | -1.07 |
| 2026-07-27 | -1.07 |
| 2026-07-24 | -1.06 |
| 2026-07-23 | -1.07 |
| 2026-07-22 | -1.07 |
| 2026-07-21 | -1.07 |
| 2026-07-20 | -1.09 |
| 2026-07-17 | -1.09 |
| 2026-07-16 | -1.10 |
| 2026-07-15 | -1.00 |
| 2026-07-14 | -1.00 |
| 2026-07-13 | -0.98 |
| 2026-07-10 | -0.97 |
| 2026-07-09 | -0.98 |
| 2026-07-08 | -0.94 |
| 2026-07-07 | -0.96 |
| 2026-07-06 | -0.96 |
| 2026-07-03 | -0.98 |
| 2026-07-02 | -0.96 |
| 2026-07-01 | -0.97 |
| 2026-06-30 | -0.94 |
| 2026-06-29 | -0.92 |